heighten focu forthcom event
growth
action rais estim peptidream lift target price
potenti return maintain outperform
invest overview peptidream februari announc
result put flesh compani busi model three pillar
collabor discoveri develop technolog licens
expans in-hous pipelin strateg allianc sinc
stock risen previou target price
compani polici disclos amount associ individu
project beyond expect peptidream book up-front payment
associ new contract sign mileston revenu project
alreadi progress consid peptidream capabl attain
goal sale higher op higher np
higher given recent increas project way end-jun
end-dec think peptidream also grow sale
profit enter new allianc reach
catalysts/risk posit includ start full-scal oper
peptistar compani conduct contract manufactur drug api
close deal concern new project neg includ sudden
announc concern suspens exist project
valuat signific chang respect base
target price dcf model use wacc termin
growth rate assumpt wacc includ market risk premium
risk free rate beta
cost debt
valuat metric
chang tp
number share mn
price month
price rel chart measur perform
topix close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price apr upsid rate outperform target price analyst fumiyoshi sakai
profit tax
issuanc retir stock
net chang cash
number share mn
charl martineau univers toronto figur profit loss statement
profit tax
chang work capit
intrins valu share jpi
equiti
debt
compani mention price
